Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-18 12:17 pm Purchase | 2025-03-06 | 13G | BioAtla, Inc. BCAB | OPOKA INVESTMENT FUND Co | 3,547,787 6.100% | 3,547,787 (New Position) | Filing History |
| 2025-02-10 5:04 pm Purchase | 2024-12-31 | 13G | BioAtla, Inc. BCAB | Highbridge Capital Management, LLC | 7,349,205 9.900% | 7,349,205 (New Position) | Filing History |
| 2025-02-07 4:41 pm Purchase | 2024-12-31 | 13G | BioAtla, Inc. BCAB | SHORT JAY M PHD | 3,865,646 6.600% | 407,456 (+11.78%) | Filing History |
| 2025-01-24 4:00 pm Sale | 2024-12-31 | 13G | BioAtla, Inc. BCAB | Millennium Management LLC | 1,095,606 1.900% | -1,319,209 (-54.63%) | Filing History |
| 2024-11-14 4:00 pm Purchase | 2024-09-30 | 13G | BioAtla, Inc. BCAB | TANG CAPITAL MANAGEMENT, LLC | 874,076 1.800% | 874,076 (New Position) | Filing History |
| 2024-10-02 4:30 pm Sale | 2024-10-01 | 13D | BioAtla, Inc. BCAB | Soleus Private Equity Fund I L.P. | 1,237,909 2.560% | -1,410,563 (-53.26%) | Filing History |
| 2024-09-06 4:59 pm Sale | 2024-08-19 | 13D | BioAtla, Inc. BCAB | Soleus Private Equity Fund I L.P. | 2,648,472 5.500% | -1,252,842 (-32.11%) | Filing History |
| 2024-08-07 4:26 pm Purchase | 2024-08-05 | 13G | BioAtla, Inc. BCAB | Millennium Management LLC | 2,414,815 5.000% | 2,414,815 (New Position) | Filing History |
| 2024-07-08 4:32 pm Sale | 2024-06-30 | 13G | BioAtla, Inc. BCAB | BlackRock Inc. BLK | 791,560 1.600% | -2,092,454 (-72.55%) | Filing History |
| 2024-04-16 09:15 am Sale | 2024-04-05 | 13D | BioAtla, Inc. BCAB | Soleus Private Equity Fund I L.P. | 3,901,314 8.100% | -319,083 (-7.56%) | Filing History |
| 2024-02-14 4:00 pm Sale | 2023-12-31 | 13G | BioAtla, Inc. BCAB | TANG CAPITAL PARTNERS LP | 2,524,076 5.300% | -600,000 (-19.21%) | Filing History |
| 2024-02-09 4:58 pm Purchase | 2023-12-31 | 13G | BioAtla, Inc. BCAB | SHORT JAY M PHD | 3,458,190 7.200% | 476,154 (+15.97%) | Filing History |
| 2024-02-06 3:57 pm Purchase | 2023-12-31 | 13G | BioAtla, Inc. BCAB | ACORN BIOVENTURES, L.P. | 4,032,046 8.400% | 1,305,591 (+47.89%) | Filing History |
| 2024-01-29 5:25 pm Purchase | 2023-12-31 | 13G | BioAtla, Inc. BCAB | BlackRock Inc. BLK | 2,884,014 6.000% | 2,884,014 (New Position) | Filing History |
| 2023-04-27 12:11 pm Purchase | 2023-04-20 | 13G | BioAtla, Inc. BCAB | ACORN BIOVENTURES, L.P. | 2,726,455 5.700% | 2,726,455 (New Position) | Filing History |
| 2023-02-27 4:14 pm Purchase | 2022-12-31 | 13G | BioAtla, Inc. BCAB | SHORT JAY M PHD | 2,982,036 6.400% | 280,709 (+10.39%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | BioAtla, Inc. BCAB | TANG CAPITAL PARTNERS LP | 3,124,076 8.600% | 835,176 (+36.49%) | Filing History |
| 2023-02-14 3:10 pm Purchase | 2022-12-31 | 13G | BioAtla, Inc. BCAB | Cormorant Asset Management LP | 3,680,365 7.980% | 1,642,150 (+80.57%) | Filing History |
| 2023-02-09 11:12 am Sale | 2022-12-30 | 13G | BioAtla, Inc. BCAB | The Vanguard Group | 1,931,039 4.190% | -333,615 (-14.73%) | Filing History |
| 2023-02-06 2:49 pm Sale | 2022-12-30 | 13G | BioAtla, Inc. BCAB | Wellington Management Group LLP | 1,102 0.000% | -3,231,378 (-99.97%) | Filing History |